Short Courses

Pharmacology in Drug Discovery and Development: New Lives for Receptors as Drug Targets Through Allostery and Biased Signaling

Sunday, February 4
8:00 AM - 3:15 PM
Location: 14B

This course discusses new ideas about efficacy (efficacy fingerprints, biased signaling) and allosteric receptor function to improve definition and quantification of GPCR drug activity, better target drug activity (i.e. pathway vs target validation) and predict therapeutic activity profiles. Specifically, methods to guide SAR for biased signaling and allosteric ligand activity will be featured.

Additional fees apply. Visit http://www.slas2018.org/program/short-course-program/ for more information.

ViewAttendees 2

Terry Kenakin

Professor
UNC School of Medicine

Presentation(s):

ViewAttendees 2

Send Email for Terry Kenakin


Assets

Pharmacology in Drug Discovery and Development: New Lives for Receptors as Drug Targets Through Allostery and Biased Signaling



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Pharmacology in Drug Discovery and Development: New Lives for Receptors as Drug Targets Through Allostery and Biased Signaling